Table 4.
Clinical studies of circulating inflammatory markers
Subjects | Major findings | References |
---|---|---|
TNFα | ||
Nondiabetic offsprings of T2DM patients | Not major contributing factor for obesity induced IR | Kellerer et al., (1996) 97 |
Adult males | Elevated in patients with T2DM | Pfeiffer et al., (1997) 96 |
Obese patients with T2DM | Correlation with the visceral fat area | Katsuki et al., (1998) 191 |
T2DM subjects | Elevated in T2DM as compared to control | Winkler et al., (1998) 192 |
Aged men | Correlation with BMI | Nilsson et al., (1998) 193 |
Canadian population | Positive correlation with IR | Zinman et al., (1999) 194 |
Obese subjects | Elevated in obese subjects than in controls | Corica et al., (1999) 195 |
Normotensive obese patients | Elevated in patients with android obesity than gynoid obesity | Winkler et al., (1999) 196 |
Obese subjects | No relationship with BMI | Kern et al., (2001) 98 |
Premenopausal obese women | Reduced after weight loss | Ziccardi et al., (2002) 197 |
Nondiabetic obese women | Associated with fat amount | Maachi et al., (2004) 198 |
Premenopausal obese women | Reduced after weight loss | Marfella et al., (2004) 199 |
IL-6 | ||
White nondiabetic subjects | Correlation with BMI | Yudkin et al., (1999) 100 |
Healthy middle-aged women | Associated with BMI | Hak et al., (1999) 200 |
Obese nondiabetic women | Reduced after weight loss | Bastard et al., (2000) 103 |
Obese subjects | Correlation with obesity and IR | Kern et al., (2001) 98 |
Pima Indians | Correlation with IR | Vozarova et al., (2001) 102 |
Premenopausal obese women | Reduced after weight loss | Ziccardi et al., (2002) 197 |
Premenopausal obese women | Reduced after weight loss | Esposito et al., (2003) 104 |
Obese patients | Reduced after weight loss | Kopp et al., (2003) 105 |
Obese subjects | Reduced after weight loss | Monzillo et al., (2003) 182 |
Premenopausal obese women | Reduced after weight loss | Giugliano et al., (2004) 106 |
Nondiabetic offspring of patients with T2DM | Not associated with the components of MS | Salmenniemi et al., (2004) 110 |
Premenopausal obese women | Reduced after weight loss | Marfella et al., (2004) 199 |
Japanese men | Not associated with the components of MS | Matsushita et al., (2006) 111 |
T2DM subjects | Associated with IR | Natali et al., (2006) 201 |
Adolescents | Positive correlation with BMI | Herder et al., (2007) 135 |
CRP | ||
White nondiabetic subjects | Positive correlation with BMI | Yudkin et al., (1999) 100 |
Healthy middle-aged women | Associated with BMI | Hak et al., (1999) 200 |
Young adults | Elevated in obese person | Visser et al., (1999) 202 |
Adult men | Correlation with body fat mass | Lemieux et al., (2001) 115 |
Obese women | Reduced after weight loss | Heilbronn et al., (2001) 117 |
Middle-aged men | Predictor of T2DM development | Freeman et al., (2002) 116 |
Obese postmenopausal women | Reduced after weight loss | Tchernof et al., (2002) 118 |
Premenopausal obese women | Reduced after weight loss | Ziccardi et al., (2002) 197 |
Healthy obese women | Correlation with IR independent of obesity | McLaughlin et al., (2002) 203 |
Premenopausal obese women | Reduced after weight loss | Esposito et al., (2003) 104 |
Healthy American women | Prognostic marker to the MS | Ridker et al., (2003) 114 |
Premenopausal obese women | Obesity is the major determinant of elevated CRP levels | Escobar-Morreale et al., (2003) 204 |
Premenopausal obese women | Reduced after weight loss | Marfella et al., (2004) 199 |
Obese subjects | Correlation with serum TNFα levels | Shadid et al., (2006) 86 |
T2DM subjects | Associated with IR | Natali et al., (2006) 201 |
Overweight women | Reduced after weight loss | Moran et al., (2007) 205 |